These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Imipramine binding sites on platelets of patients with major depressive disorder. Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818 [TBL] [Abstract][Full Text] [Related]
9. Differential 3H-imipramine platelet binding in patients with panic disorder and depression. Innis RB; Charney DS; Heninger GR Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580 [TBL] [Abstract][Full Text] [Related]
10. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192 [TBL] [Abstract][Full Text] [Related]
11. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls. Nankai M; Yoshimoto S; Narita K; Takahashi R J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144 [TBL] [Abstract][Full Text] [Related]
12. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity. Tanimoto K; Maeda K; Terada T Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789 [No Abstract] [Full Text] [Related]
13. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis. Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404 [No Abstract] [Full Text] [Related]
14. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets. Arora RC; Wunnicke V; Meltzer HY Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127 [TBL] [Abstract][Full Text] [Related]
15. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects. Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612 [TBL] [Abstract][Full Text] [Related]
16. Modifications of [3H]imipramine binding sites in platelets of chronic pain patients treated with mianserin. Magni G; Andreoli F; Arduino C; Arsie D; Ceccherelli F; Ambrosio F; Dodi G; Eandi M Pain; 1987 Sep; 30(3):311-320. PubMed ID: 3670878 [TBL] [Abstract][Full Text] [Related]
17. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients. Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002 [TBL] [Abstract][Full Text] [Related]
18. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression. Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267 [TBL] [Abstract][Full Text] [Related]
19. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment. Hrdina PD; Lapierre YD; Horn ER; Bakish D Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804 [TBL] [Abstract][Full Text] [Related]
20. Imipramine binding in depression and other psychiatric conditions. Mellerup ET; Plenge P Acta Psychiatr Scand Suppl; 1988; 345():61-8. PubMed ID: 2852451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]